Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC ...Middle East

Medscape - News
The first comparator study shows that the novel radiopharmaceutical Lu-PSMA-6170 bettered chemotherapy for metastatic castration-resistant prostate cancer (mCRPC). Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Novel Radiopharmaceutical Beats Cabazitaxel in mCRPC )

Apple Storegoogle play

Also on site :

Most viewed in News